Cutler Group LP Omeros Corp Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 04, 2022	SELL	$1.92 - $6.28 $960 - $3,140	-500 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$5.07 - $7.2 $101,400 - $144,000	-20,000 Reduced 97.56%	500 $0
Q4 2021 Jan 18, 2022	SELL	$5.67 - $8.54 $53,298 - $80,275	-9,400 Reduced 31.44%	20,500 $74,000
Q3 2021 Oct 26, 2021	BUY	$13.4 - $16.3 $395,300 - $480,850	29,500 Added 7375.0%	29,900 $29,000
Q3 2020 Oct 27, 2020	BUY	$9.57 - $21.32 $1,914 - $4,264	200 Added 100.0%	400 $3,000
Q1 2018 May 11, 2018	SELL	$9.0 - $20.16 $104,400 - $233,856	-11,600 Reduced 98.31%	200 $0
Q3 2017 Oct 17, 2017	BUY	$19.76 - $24.9 $233,168 - $293,820	11,800	11,800 $5,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.